The Modified Frailty Index (mFI-11) Predicts Adverse Outcomes After Surgery for Lower-Extremity Nonmelanoma Skin Cancer
BACKGROUND: The lower extremity is a high-risk site for complications after dermatologic surgery, yet validated tools for preoperative risk stratification are lacking. The 11-item modified Frailty Index (mFI-11) predicts surgical morbidity across numerous specialties but has not been studied in dermatologic surgery. OBJECTIVE: To determine whether the mFI-11 predicts adverse outcomes after surgery for lower-extremity nonmelanoma skin cancer (NMSC). METHODS: Retrospective review of 103 cases of biopsy-proven invasive lower-extremity NMSC treated with excision or Mohs micrographic surgery at a single academic center between 2023 and 2026. Outcomes were analyzed with cluster-robust logistic and Poisson regression. RESULTS: Adverse events occurred in 38% of cases, increasing monotonically across frailty categories (23% to 67%). Frail patients (≥3 mFI-11 items) had greater odds of any adverse event (67% vs 29%; OR 4.87; 95% CI 1.81-13.07), more complications per case (rate ratio 1.32 per item), longer wound-care episodes (median 48 vs 21 days), and more frequent wound-care escalation (54% vs 15%). Frailty remained independently predictive after adjustment for defect size, age, and sex (adjusted OR 1.69 per item; 95% CI 1.17-2.43). CONCLUSION: The mFI-11 is a low-cost, graded, independent predictor of adverse outcomes after lower-extremity NMSC surgery and may aid preoperative risk stratification and counseling.
Authors
- Christine Learned
- C. Chen
- Bichchau Nguyen (ORCID: https://orcid.org/0000-0002-4751-1559)
- Mari Yasumi
- Cameron Neeson
Institutions
- Tufts University (US)
- Tufts Medical Center (US)
Publication Details
- Journal
- Dermatologic Surgery
- Published
- 2026-11-19
- DOI
- https://doi.org/10.1097/dss.0000000000005457
- Primary Topic
- Frailty in Older Adults
- Type
- article
- Field-Weighted Citation Impact
- 0.00